-
Manufacturing ServicesNovo Refiles $16.5 Bn Catalent Acquisition to Extend FTC Review Period
4 min read • 2 years ago -
Regulatory & ComplianceFDA Approves First BCMA-Targeted Relapsed or Refractory Multiple Myeloma Therapy
4 min read • 2 years ago -
-
-
-
-
-
Regulatory & ComplianceFDA Rejects Regeneron’s Blood Cancer Therapy Odronextamab Pending More Data
4 min read • 2 years ago -
Funding & InvestmentsLilly Reinforces Chinese Market Commitment Amidst US-China Biotech Tensions
4 min read • 2 years ago -
Unlocking the Future of Biotechnology.
Access unparalleled market intelligence, R&D clinical trial tracking, and editorial authority from the industry's most trusted navigators.
TRUSTED BY 20,000+ INDUSTRY ANALYSTS
Log in
Enter your credentials to continue.
